Corona Remedies Ltd

NSE: CORONA · BSE: 544644 · Pharmaceuticals & Biotechnology · 22 announcements

Share price: ₹2,042.90
Market cap: ₹12,494 Cr
Revenue (annual): ₹1,403 Cr
Net profit (annual): ₹185.1 Cr
P/E (TTM): 62.8×Sector 47.4×
Promoter holding: 69.00%+0.00% QoQ
FII holding: 3.63%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Financial Results 3 Board Meeting Date 3 Results Update 2 Annual General Meeting 2 Regulatory Approval 1 Production Started 1 Price Movement Clarification 1 Other Announcement 1 Dividend 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 May 2026 15:34 IST BSE

Regulatory Approval

Corona Remedies Regulatory Approval

Corona Remedies received EU-GMP certification for its Hormone facility and renewed approval for its OSD plant. These accreditations support the company's global pharmaceutical market expansion.

Read the filing ↗